MARKET

DVHGF

DVHGF

DEVONIAN HEALTH GROUP INC
OTCMQB
7.00
NaN%
Opening 09:30 07/27 EDT
OPEN
--
PREV CLOSE
7.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
10.80
52 WEEK LOW
4.266
MARKET CAP
19.36M
P/E (TTM)
-3.5638
1D
5D
1M
3M
1Y
5Y
1D
Health Canada clears Devonian to start pediatric Phase II/III Thykamine atopic dermatitis trial
PUBT · 6d ago
DEVONIAN HEALTH GROUP - STUDY TO EVALUATE THYKAMINE 0.05% AND 0.1% CREAM VERSUS PLACEBO
Reuters · 6d ago
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
PR Newswire · 6d ago
Devonian Q3 FY26 net loss narrows to C$1.9 million; cash drops to C$0.7 million as of April 30, 2026
PUBT · 06/30 00:00
Devonian Health Group shareholders approved option plan amendment increasing shares reserved to 20%
Reuters · 03/30 20:01
Devonian Health Group GAAP EPS of -$0.81
Seeking Alpha · 03/26 18:58
Devonian Health Group FY2026 Q2 net loss widens to C$2.2 million; loss per share widens to C$0.81
Reuters · 03/25 20:23
DEVONIAN HEALTH GROUP INC - IS ACTIVELY EVALUATING STRATEGIC ALTERNATIVES FOR ALTIUS BUSINESS WHILE PURSUING FINANCING OPTIONS TO SUPPORT ITS PIPELINE
Reuters · 03/25 20:23
More
About DVHGF
Devonian Health Group Inc. is a clinical stage pharmaceutical company specializing in the development of drugs for various autoimmune fibroinflammatory diseases with novel therapeutic approaches to targeting unmet medical needs. The Company is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis. It is also involved in the development of cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its Thykamine is an active lead drug candidate with safety and profiles confirmed in several pre-clinical and clinical studies targeting inflammation. Its cosmeceutical products include R-Spinasome and Purgenesis. The Company’s subsidiary, Altius Healthcare LP, focused on selling prescription pharmaceutical products in Canada, under licenses from brand-name pharmaceutical companies.

Webull offers Devonian Health Group Inc stock information, including OTCMQB: DVHGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVHGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DVHGF stock methods without spending real money on the virtual paper trading platform.